Related Experiment Video

Updated: Jun 12, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Immediate and long-term outcome of multiple percutaneous interventions in patients with rheumatic valvular stenosis

Osama Rifaie1, Adel El-Itriby, Tarek Zaki

  • 1Faculty of Medicine, Aim Shams University, Cardiology Department, Cairo, Egypt.

Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
|June 22, 2010
PubMed

Insights

Percutaneous balloon valvuloplasty effectively treats rheumatic valvular stenosis, showing good immediate and long-term results for mitral, aortic, and tricuspid valves.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Valvular Heart Disease

Background:

  • Rheumatic heart disease commonly causes valvular stenosis.
  • Percutaneous valvuloplasty offers a less invasive treatment option.

Purpose of the Study:

  • To evaluate the immediate and long-term outcomes of combined percutaneous valvuloplasty for mitral, aortic, and tricuspid valves in rheumatic stenosis.
  • To assess the feasibility and efficacy of these procedures.

Main Methods:

  • Eleven patients with rheumatic valvular stenosis underwent combined percutaneous mitral valvuloplasty (PMV), percutaneous aortic valvuloplasty (PAV), and/or percutaneous tricuspid valvuloplasty (PTV).
  • Procedures utilized standard double balloon techniques and retrograde/antegrade approaches for PAV.
  • Echocardiography assessed outcomes pre- and post-procedure, with follow-up up to 60 months.

Main Results:

  • Immediate success rates were high: PMV (91%), PAV (100%), PTV (80%).
  • Long-term follow-up showed low restenosis rates for PMV (9%) and PAV (0%), but higher for PTV (40%).

Conclusions:

  • Percutaneous balloon dilatation is a feasible treatment for rheumatic valvular stenosis.
  • The procedure demonstrates adequate immediate and long-term outcomes, particularly for mitral and aortic valves.
Abstract

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...